. >> i think zelnick changed the whole narrative. >> we used to talk about -- it was right, about was it too early. >> but if you like that farmville? >> i don't play farmville. >> they just play candy crush. >> candy crush is owned by microsoft? >> no. >> my wife is watching the "mayor of kingstown" and a lot of people multitask. >> i've watched it i'm not watching the kingtown. is that on paramount -- >> paramount plus. >> the name you wanted to own this year was discovery. it's not because of -- >> how about viacom today. >> jessica reef got involved last week. >> i call her that -- >> let's get to the take-two deal, guys 9.86 a share we see colallers, but -- you're going to have that -- take-two looks like it will be down as much as 2%, but that will not impact the overall value of the deal, at least or until -- it is below the 156 of the bottom of the collar you will start to see a bit of value erode. the ratio, though, the collar is 156 to 181 or 182, therefore the ratio changes to maintain the of 36 in -- by the way, jim the all-time higher is higher. it was -- >> i'm sorry, ri

zelnick was with us a couple weeks ago where he received a scoff at the metaverse, so it's interesting gary gensler is coming up first, we'll be hearing from albert bourla. what does the potential booster picture look like later this year all that and more on the way as we head to the break, check out the surging shares of tilray, reporting a surprise second quarter profit. students you're watching squawk on cnbc ♪ ♪ ♪ ♪ [music: “you can get it if you really want” by jimmy cliff] >>> welcome back to "squawk box. all day today cnbc will bring you the biggest names from the healthcare conference. meg tirrell joins us with another special guest. >> andrew, thanks so much. that's albert bourla thanks for being with us this morning. of course, you also expanded your relationship focusing on a shingles vaccine how much of a driver of your business going forward do you expect that to be? >> well, i think it's going to be a driver of finding solutions for our medical sneeze we have a strong belief in the technothe best of mankindir you have seen where we're standing further, this is a corrobor